STOCK TITAN

Agilent (NYSE: A) director granted 2,158 fully vested common shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rataj Sue H. reported acquisition or exercise transactions in this Form 4 filing.

AGILENT TECHNOLOGIES, INC. director Sue H. Rataj received an award of 2,158 shares of common stock on March 19, 2026. The shares were granted as compensation for service as a non-employee director and were fully vested upon grant at a reference price of $111.75 per share. Following this award, she directly holds 23,617 shares of Agilent common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rataj Sue H.

(Last)(First)(Middle)
5301 STEVENS CREEK BLVD

(Street)
SANTA CLARA CALIFORNIA 95051

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/19/2026A2,158A$111.75(1)23,617D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.
Remarks:
See Exhibit 24 - Power of Attorney
/s/ Shirley Qin, attorney-in-fact for Mrs. Rataj03/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Agilent (A) report for director Sue H. Rataj?

Agilent reported that director Sue H. Rataj received 2,158 shares of common stock as a fully vested stock award. This was a compensation-related grant, not an open-market purchase or sale, and increased her direct holdings to 23,617 shares.

Was the Agilent (A) Form 4 transaction an open-market buy or sell?

The Form 4 shows a grant of 2,158 Agilent shares to director Sue H. Rataj, not an open-market buy or sale. It is coded as an award acquisition, reflecting routine non-employee director compensation fully vested at the time of grant.

At what price was Sue H. Rataj’s Agilent (A) stock award recorded?

The 2,158-share award to Sue H. Rataj was recorded at $111.75 per share. This price is the transaction value reported for the grant on the Form 4 and is used to calculate the award’s total reported value, not a trade execution price.

How many Agilent (A) shares does Sue H. Rataj hold after this Form 4?

After receiving the 2,158-share award, Sue H. Rataj directly holds 23,617 Agilent common shares. This total, disclosed in the Form 4, reflects her updated direct ownership position as a non-employee director following the compensation grant.

What does the footnote on Sue H. Rataj’s Agilent (A) stock grant explain?

The footnote explains the shares were acquired from an award of Agilent common stock for non-employee directors. It clarifies the award is fully vested upon grant, confirming these shares are immediately owned and not subject to additional vesting conditions.
Agilent Technologies Inc

NYSE:A

View A Stock Overview

A Rankings

A Latest News

A Latest SEC Filings

A Stock Data

31.66B
282.05M
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SANTA CLARA